ロード中...
Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels
AIMS: The mode of action by which doxapram acts as a respiratory stimulant in humans is controversial. Studies in rodent models, have shown that doxapram is a more potent and selective inhibitor of TASK‐1 and TASK‐1/TASK‐3 heterodimer channels, than TASK‐3. Here we investigate the direct effect of d...
保存先:
| 出版年: | Acta Physiol (Oxf) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003846/ https://ncbi.nlm.nih.gov/pubmed/31423744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apha.13361 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|